X0306 4 2015-06-05 0001289340 Stereotaxis, Inc. STXS 0001267959 MIDDLETON FRED A C/O STEREOTAXIS, INC. 4320 FOREST PARK AVENUE, SUITE 100 ST. LOUIS MO 63108 1 0 0 0 Common Stock 46810 D Common Stock 2015-06-05 4 S 0 55476 1.69 D 1200926 I Sanderling Venture Partners VI Co-Investment Fund, L.P. Common Stock 2015-06-08 4 S 0 38120 1.60 D 1162806 I Sanderling Venture Partners VI Co-Investment Fund, L.P. Common Stock 2015-06-09 4 S 0 13280 1.60 D 1149526 I Sanderling Venture Partners VI Co-Investment Fund, L.P. Common Stock 40673 I Sanderling Ventures Management VI Common Stock 6358 I Sanderling VI Limited Partnership Common Stock 5335 I Sanderling VI Beteiligungs GmbH & Co. KG Common Stock 1500 I Sanderling Mgmt. LLC 401K Pension Profit Sharing Plan Common Stock 53275 I Sanderling IV Biomedical Co-Investment Fund, L.P. Common Stock 11097 I Sanderling V Beteiligungs GmbH & Co. KG Common Stock 39716 I Sanderling V Biomedical Co-Investment Fund, L.P. Common Stock 11956 I Sanderling V Limited Partnership Common Stock 67790 I Sanderling Venture Partners V Co-Investment Fund, L.P. Common Stock 22451 I Sanderling Venture Partners IV Co-Investment Fund Common Stock 82 I Sanderling Ventures Management V The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.63 to $1.73, inclusive. The reporting person undertakes to provide to Stereotaxis, Inc., any security holder of Stereotaxis, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.60 to $1.63, inclusive. The reporting person undertakes to provide to Stereotaxis, Inc., any security holder of Stereotaxis, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.60 to $1.62, inclusive. The reporting person undertakes to provide to Stereotaxis, Inc., any security holder of Stereotaxis, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Karen W. Duros, Attorney-in-Fact 2015-06-09